Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001358762-11-000001
Filing Date
2011-07-13
Accepted
2011-07-13 15:18:43
Documents
1
Effectiveness Date
2011-07-13
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 17663
  Complete submission text file 0001358762-11-000001.txt   18691
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

EIN.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-162812 | Film No.: 11965776